Stocktoria
Corvus Pharmaceuticals, Inc. CRVS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-03-23
Corvus Pharmaceuticals, Inc. statistics & valuation
Market cap$1.1B
P / B18.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2025 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| Return on assets | -21.5% | — | — | -90.4% | -59.3% |
| Return on equity | -25.0% | — | — | -191.3% | -69.9% |
| Current ratio | 6.21 | 8.91 | 4.90 | 1.54 | 4.07 |
Source: SEC EDGAR filings · CIK 0001626971 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.